Wafa Sosal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wafa Sosal has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Leena Khalid
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
3 shared publications Sasidhar Gunturu
BronxCare Health System, New York USA
3 shared publicationsAmina Hanif
Bronxcare Health System New York New York USA
2 shared publications- Mohamed Mbbs Husham Mohamed Elbadawi
Faculty of Medicine University of Khartoum Khartoum Sudan
2 shared publications Saad Ather
SUNY Upstate Medical University New York New York USA
2 shared publications- Sakshi Prasad
Bronxcare Health System New York New York USA
2 shared publications
Latest Publications
- 30 January 2026
- Published by Elsevier in Disease-a-Month
- Vol. 72 (4) , 102064
Lithium: A review of its adverse effects, toxicity and discontinuation
- 30 January 2026
- Published by Elsevier in Disease-a-Month
- Vol. 72 (4) , 102064
Lithium: A review of its adverse effects, toxicity and discontinuation
- Open Access
- 19 December 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
The Interconnected Factors of Emotional Regulation, Trauma, and Substance Use in Non‐Suicidal Self‐Injury: A Case Study and Literature Review
Non‐suicidal self‐injury (NSSI) is a complex and often misunderstood behavior linked to emotional dysregulation, trauma, and substance use. In this case report we present a 19‐year‐old female with a history of childhood trauma and substance use, who engaged in self‐injurious behavior as a coping mechanism to manage distress and maintain sobriety. Through her narrative and clinical course, we explore the multifaceted drivers of NSSI, its diagnostic considerations, and therapeutic interventions including dialectical behavior therapy. This case report underscores the importance of trauma‐informed, individualized care and highlights emerging insights into the neurobiological underpinnings of self‐injury. This case advocates for early recognition, compassionate engagement, and integrated treatment approaches to support recovery.
- 19 December 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
Open AccessThe Interconnected Factors of Emotional Regulation, Trauma, and Substance Use in Non‐Suicidal Self‐Injury: A Case Study and Literature Review
Non‐suicidal self‐injury (NSSI) is a complex and often misunderstood behavior linked to emotional dysregulation, trauma, and substance use. In this case report we present a 19‐year‐old female with a history of childhood trauma and substance use, who engaged in self‐injurious behavior as a coping mechanism to manage distress and maintain sobriety. Through her narrative and clinical course, we explore the multifaceted drivers of NSSI, its diagnostic considerations, and therapeutic interventions including dialectical behavior therapy. This case report underscores the importance of trauma‐informed, individualized care and highlights emerging insights into the neurobiological underpinnings of self‐injury. This case advocates for early recognition, compassionate engagement, and integrated treatment approaches to support recovery.
- Open Access
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42350
Prevalence of depression among diabetic patients and its relationship to diabetes self-care activities, disease profile, and social factors in Khartoum State, Sudan: A cross-sectional study
Depression is common among individuals with diabetes mellitus, yet many cases go undiagnosed. It is linked to poorer treatment outcomes. However, data from developing countries remains limited. This study aimed to assess the prevalence and severity of depression among diabetic patients in Khartoum State. It also examined the association between depression and diabetes self-care activities in addition to other clinical and personal factors. A descriptive cross-sectional study was conducted at 3 diabetic outpatient clinics in Khartoum State. Depression was measured using the Patient Health Questionnaire 9, while diabetes self-management behaviors were evaluated using the Self-Reported Diabetes Self-Care Activities Questionnaire. Clinical and personal characteristics were also collected. Associations between depression and various factors were analyzed using the chi-square test and Fisher’s exact test, with a P -value of less than .05 considered statistically significant. A total of 163 participants were included. The overall prevalence of depression among diabetic patients was 86.5%, with the majority experiencing minimal (33.1%) and mild (30.1%) depression. Depression was significantly associated with the type of diabetes medications ( P = .011) and a family history of psychiatric illness ( P = .001). Depression was also significantly linked to the loss of a close person ( P -value = .001) and lack of social support ( P -value = .018), as well as various aspects of diabetes self-care activities. This study revealed a high prevalence of depression among diabetic patients in Khartoum State. Depression was strongly associated with various diabetes self-care activities as well as other clinical and personal factors. Integrating mental health support into diabetes care programs is essential to improve outcomes. Future population-based studies with more robust methodologies are recommended.
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42350
Open AccessPrevalence of depression among diabetic patients and its relationship to diabetes self-care activities, disease profile, and social factors in Khartoum State, Sudan: A cross-sectional study
Depression is common among individuals with diabetes mellitus, yet many cases go undiagnosed. It is linked to poorer treatment outcomes. However, data from developing countries remains limited. This study aimed to assess the prevalence and severity of depression among diabetic patients in Khartoum State. It also examined the association between depression and diabetes self-care activities in addition to other clinical and personal factors. A descriptive cross-sectional study was conducted at 3 diabetic outpatient clinics in Khartoum State. Depression was measured using the Patient Health Questionnaire 9, while diabetes self-management behaviors were evaluated using the Self-Reported Diabetes Self-Care Activities Questionnaire. Clinical and personal characteristics were also collected. Associations between depression and various factors were analyzed using the chi-square test and Fisher’s exact test, with a P -value of less than .05 considered statistically significant. A total of 163 participants were included. The overall prevalence of depression among diabetic patients was 86.5%, with the majority experiencing minimal (33.1%) and mild (30.1%) depression. Depression was significantly associated with the type of diabetes medications ( P = .011) and a family history of psychiatric illness ( P = .001). Depression was also significantly linked to the loss of a close person ( P -value = .001) and lack of social support ( P -value = .018), as well as various aspects of diabetes self-care activities. This study revealed a high prevalence of depression among diabetic patients in Khartoum State. Depression was strongly associated with various diabetes self-care activities as well as other clinical and personal factors. Integrating mental health support into diabetes care programs is essential to improve outcomes. Future population-based studies with more robust methodologies are recommended.
- Open Access
- 22 April 2025
- Published by Wiley
The Interconnected Factors of Emotional Regulation, Trauma, and Substance Use in Non-Suicidal Self-Injury: A Case Study and Literature Review
- 22 April 2025
- Published by Wiley
Open AccessThe Interconnected Factors of Emotional Regulation, Trauma, and Substance Use in Non-Suicidal Self-Injury: A Case Study and Literature Review
- 24 February 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 41 (4) , e55-e57
Catatonia in a Patient With Lissencephaly Treated With ECT
Catatonia is a neuropsychiatric syndrome that occurs with several psychiatric and systemic medical conditions. Central nervous system abnormalities are believed to increase the risk of catatonia, with several cases reported in patients with neurodevelopmental and neurodegenerative disorders. Lissencephaly is a spectrum of neuronal migration disorders characterized by poorly defined or absent gyri and sulci, abnormally thick cortex, and a broad array of histopathological changes. Lissencephaly has a range of etiologies, clinical signs, symptoms, and degrees of severity. It is associated with comorbidities, such as epilepsy, visual, cardiac, and skeletal problems, as well as premature mortality. In this article, we describe the case of a patient with lissencephaly who developed catatonia at 20 years of age. He was minimally responsive to treatment with a high dose of lorazepam, and catatonia subsided with the use of electroconvulsive therapy. This is the first case in our knowledge to describe the occurrence of catatonia among patients with lissencephaly and its treatment with electroconvulsive therapy.
- 24 February 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 41 (4) , e55-e57
Catatonia in a Patient With Lissencephaly Treated With ECT
Catatonia is a neuropsychiatric syndrome that occurs with several psychiatric and systemic medical conditions. Central nervous system abnormalities are believed to increase the risk of catatonia, with several cases reported in patients with neurodevelopmental and neurodegenerative disorders. Lissencephaly is a spectrum of neuronal migration disorders characterized by poorly defined or absent gyri and sulci, abnormally thick cortex, and a broad array of histopathological changes. Lissencephaly has a range of etiologies, clinical signs, symptoms, and degrees of severity. It is associated with comorbidities, such as epilepsy, visual, cardiac, and skeletal problems, as well as premature mortality. In this article, we describe the case of a patient with lissencephaly who developed catatonia at 20 years of age. He was minimally responsive to treatment with a high dose of lorazepam, and catatonia subsided with the use of electroconvulsive therapy. This is the first case in our knowledge to describe the occurrence of catatonia among patients with lissencephaly and its treatment with electroconvulsive therapy.
- Open Access
- 4 September 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6488-6494
Exploring the effect of diet programs on the behavior of Sudanese children with autism and the prevalence and association of gastrointestinal symptoms: a multi-center cross-sectional study
Background and aims: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social difficulties, speech and nonverbal communication issues, and restricted behaviors. Nutritional issues, such as food allergies and intolerances, can affect children with ASD. This study aimed to evaluate the impact of diet programs on ASD behavior and gastrointestinal symptoms, which would be considered as a starting point to increase the family’s knowledge about how to practice healthy and suitable dieting for their children. Materials and methods: The study was a cross-sectional observational study on 45 children with an autism spectrum disorder in four centers aged 2–18 in Khartoum state. Data was collected through an interview questionnaire, which included sociodemographic, diet, gastrointestinal, and behavioral assessments. The data was analyzed using SPSS to find the correlation between the various variables. Independent t-test, Analysis of Variance, and Mann–Whitney test were used in univariant analysis to assess the association between study variables, while multiple linear regression was used in multivariant analysis for the same purpose Results: The study involved a large number of children with autism spectrum disorder (ASD), with 80% being male and 73.3% being school-aged. Most had parents as guardians and 71.1% were in intermediate financial status. About 20% were overweight or obese, and 57.8% did not have a specific diet program. Food selectivity was prevalent, with 22.7% having allergies to milk and wheat. ASD children experienced vomiting, gastric reflux, abdominal pain, and changes in stool characteristics. A significant link was found between financial status, behavioral status and gastrointestinal changes. High financial status was significantly different from intermediate and low statuses based on behavioral changes. However, no significant association was found in multivariant analysis. Conclusion: The study found that ASD children generally have good nutritional health, with a higher degree of dietary selection. The financial status of guardians significantly influenced behavioral and gastrointestinal changes in the children. Further interventional studies are recommended to assess the direct impact of diet programs on these symptoms.
- 4 September 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6488-6494
Open AccessExploring the effect of diet programs on the behavior of Sudanese children with autism and the prevalence and association of gastrointestinal symptoms: a multi-center cross-sectional study
Background and aims: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social difficulties, speech and nonverbal communication issues, and restricted behaviors. Nutritional issues, such as food allergies and intolerances, can affect children with ASD. This study aimed to evaluate the impact of diet programs on ASD behavior and gastrointestinal symptoms, which would be considered as a starting point to increase the family’s knowledge about how to practice healthy and suitable dieting for their children. Materials and methods: The study was a cross-sectional observational study on 45 children with an autism spectrum disorder in four centers aged 2–18 in Khartoum state. Data was collected through an interview questionnaire, which included sociodemographic, diet, gastrointestinal, and behavioral assessments. The data was analyzed using SPSS to find the correlation between the various variables. Independent t-test, Analysis of Variance, and Mann–Whitney test were used in univariant analysis to assess the association between study variables, while multiple linear regression was used in multivariant analysis for the same purpose Results: The study involved a large number of children with autism spectrum disorder (ASD), with 80% being male and 73.3% being school-aged. Most had parents as guardians and 71.1% were in intermediate financial status. About 20% were overweight or obese, and 57.8% did not have a specific diet program. Food selectivity was prevalent, with 22.7% having allergies to milk and wheat. ASD children experienced vomiting, gastric reflux, abdominal pain, and changes in stool characteristics. A significant link was found between financial status, behavioral status and gastrointestinal changes. High financial status was significantly different from intermediate and low statuses based on behavioral changes. However, no significant association was found in multivariant analysis. Conclusion: The study found that ASD children generally have good nutritional health, with a higher degree of dietary selection. The financial status of guardians significantly influenced behavioral and gastrointestinal changes in the children. Further interventional studies are recommended to assess the direct impact of diet programs on these symptoms.
- Open Access
- 1 January 2024
- Published by Wiley in Case Reports in Psychiatry
- Vol. 2024 (1) , 8845349
Agitated Depression Associated With Flurazepam Discontinuation
Agitated depression, also known as melancholia agitata, is a variant of depression characterized by severe symptoms of psychomotor agitation, inner unrest, anxiety, restlessness, prominent vegetative symptoms, and a high risk of suicide. This form of depression is reported to worsen with antidepressants and potentially improve with the use of ECT, lithium, antiepileptics, antipsychotics, and benzodiazepines. We describe a case of a 73‐year‐old female with a prior history of depression and generalized anxiety disorder who was maintained on flurazepam for 44 years and was admitted for severe depression with psychomotor agitation, prominent vegetative symptoms, thought perseveration, indecisiveness, and psychotic features that emerged following the discontinuation of flurazepam. Symptoms did not resolve with the use of alternative benzodiazepines such as nitrazepam and temazepam and further worsened with the use of several antidepressants. She finally had a complete resolution of these symptoms with a combination of alprazolam, zopiclone, and olanzapine. This case provides insight into this unique variant of depression and the role of GABA agonists in its pathology and management.
- 1 January 2024
- Published by Wiley in Case Reports in Psychiatry
- Vol. 2024 (1) , 8845349
Open AccessAgitated Depression Associated With Flurazepam Discontinuation
Agitated depression, also known as melancholia agitata, is a variant of depression characterized by severe symptoms of psychomotor agitation, inner unrest, anxiety, restlessness, prominent vegetative symptoms, and a high risk of suicide. This form of depression is reported to worsen with antidepressants and potentially improve with the use of ECT, lithium, antiepileptics, antipsychotics, and benzodiazepines. We describe a case of a 73‐year‐old female with a prior history of depression and generalized anxiety disorder who was maintained on flurazepam for 44 years and was admitted for severe depression with psychomotor agitation, prominent vegetative symptoms, thought perseveration, indecisiveness, and psychotic features that emerged following the discontinuation of flurazepam. Symptoms did not resolve with the use of alternative benzodiazepines such as nitrazepam and temazepam and further worsened with the use of several antidepressants. She finally had a complete resolution of these symptoms with a combination of alprazolam, zopiclone, and olanzapine. This case provides insight into this unique variant of depression and the role of GABA agonists in its pathology and management.